Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1963 2
1966 1
1967 1
1968 2
1973 1
1975 1
1976 2
1977 3
1979 1
1981 7
1982 3
1983 2
1986 2
1987 2
1989 3
1990 2
1991 5
1992 3
1993 2
1994 2
1995 3
1996 6
1997 1
1998 5
1999 5
2000 4
2001 4
2002 4
2003 8
2004 8
2005 11
2006 9
2007 10
2008 12
2009 18
2010 18
2011 16
2012 9
2013 19
2014 17
2015 13
2016 15
2017 10
2018 5
2019 8
2020 12
2021 23
2022 31
2023 26
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

356 results

Results by year

Filters applied: . Clear all
Page 1
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Bidard FC, Hardy-Bessard AC, Dalenc F, Bachelot T, Pierga JY, de la Motte Rouge T, Sabatier R, Dubot C, Frenel JS, Ferrero JM, Ladoire S, Levy C, Mouret-Reynier MA, Lortholary A, Grenier J, Chakiba C, Stefani L, Plaza JE, Clatot F, Teixeira L, D'Hondt V, Vegas H, Derbel O, Garnier-Tixidre C, Canon JL, Pistilli B, André F, Arnould L, Pradines A, Bièche I, Callens C, Lemonnier J, Berger F, Delaloge S; PADA-1 investigators. Bidard FC, et al. Among authors: plaza je. Lancet Oncol. 2022 Nov;23(11):1367-1377. doi: 10.1016/S1470-2045(22)00555-1. Epub 2022 Sep 29. Lancet Oncol. 2022. PMID: 36183733 Clinical Trial.
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748.
Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, de Oliveira Araujo IB, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Di Napoli A, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Suzuki R, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W; International Agency for Research on Cancer/World Health Organization. Alaggio R, et al. Leukemia. 2023 Sep;37(9):1944-1951. doi: 10.1038/s41375-023-01962-5. Leukemia. 2023. PMID: 37468552 Free PMC article. No abstract available.
Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in oestrogen receptor-positive, HER2-negative metastatic breast cancer patients: study design of PADA-1.
Berger F, Marce M, Delaloge S, Hardy-Bessard AC, Bachelot T, Bièche I, Pradines A, De La Motte Rouge T, Canon JL, André F, Arnould L, Clatot F, Lemonnier J, Marques S, Bidard FC; PADA-1 investigators. Berger F, et al. BMJ Open. 2022 Mar 3;12(3):e055821. doi: 10.1136/bmjopen-2021-055821. BMJ Open. 2022. PMID: 35241469 Free PMC article. Clinical Trial.
Robotic probes at the cell scale.
Plaza JA. Plaza JA. Sci Robot. 2023 Jan 25;8(74):eadf9996. doi: 10.1126/scirobotics.adf9996. Epub 2023 Jan 25. Sci Robot. 2023. PMID: 36696475 Review.
Nanoparticles for photothermal therapies.
Jaque D, Martínez Maestro L, del Rosal B, Haro-Gonzalez P, Benayas A, Plaza JL, Martín Rodríguez E, García Solé J. Jaque D, et al. Among authors: plaza jl. Nanoscale. 2014 Aug 21;6(16):9494-530. doi: 10.1039/c4nr00708e. Nanoscale. 2014. PMID: 25030381 Review.
Iododerma Simulating Cryptococcal Infection.
Korman AM, Plaza JA, Kaffenberger BH. Korman AM, et al. Among authors: plaza ja. Cutis. 2023 Oct;112(4):E7-E9. doi: 10.12788/cutis.0873. Cutis. 2023. PMID: 37988312 No abstract available.
Cutaneous Manifestations of Rheumatoid Arthritis: Diagnosis and Treatment.
Diaz MJ, Natarelli N, Wei A, Rechdan M, Botto E, Tran JT, Forouzandeh M, Plaza JA, Kaffenberger BH. Diaz MJ, et al. Among authors: plaza ja. J Pers Med. 2023 Oct 10;13(10):1479. doi: 10.3390/jpm13101479. J Pers Med. 2023. PMID: 37888090 Free PMC article. Review.
Surgery for pancreatic ductal adenocarcinoma.
Vera R, Díez L, Martín Pérez E, Plaza JC, Sanjuanbenito A, Carrato A. Vera R, et al. Among authors: plaza jc. Clin Transl Oncol. 2017 Nov;19(11):1303-1311. doi: 10.1007/s12094-017-1688-0. Epub 2017 Jun 23. Clin Transl Oncol. 2017. PMID: 28646282 Review.
Metastatic Spiradenocarcinoma Managed With PD-1 Inhibition.
Wargo JJ, Carr DR, Plaza JA, Verschraegen CF. Wargo JJ, et al. Among authors: plaza ja. J Natl Compr Canc Netw. 2022 Feb 23:1-3. doi: 10.6004/jnccn.2021.7119. Online ahead of print. J Natl Compr Canc Netw. 2022. PMID: 35196645
356 results